News stories about Advisory Board (NASDAQ:ABCO) have trended somewhat positive on Thursday, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Advisory Board earned a coverage optimism score of 0.24 on Accern’s scale. Accern also assigned news coverage about the business services provider an impact score of 44.6964431224231 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news articles that may have effected Accern Sentiment’s analysis:
- There’s not a crisis of uninsured people overusing the emergency room (vox.com)
- Sionic Mobile Expands Advisory Board, Adding Veteran Travel and Payments Executives (markets.financialcontent.com)
- DermTech Announces Addition of Ronald Moy to Scientific Advisory Board (markets.financialcontent.com)
- iSign has Added Another Key Member to its Team Battling to Rid the World of Cybercrime as Dr. Jason Shen, PhD has accepted a position on iSign’s Advisory Board (prweb.com)
- Jay Crowley, Grant Hodgkins to Present at the MDR & IVDR EU Conference 2017 in Orlando, Florida for USDM Life Sciences (prweb.com)
Advisory Board (NASDAQ:ABCO) traded up $0.05 during trading hours on Thursday, hitting $53.83. 895,100 shares of the stock traded hands, compared to its average volume of 788,742. The company has a market cap of $2,190.00, a price-to-earnings ratio of 32.23, a P/E/G ratio of 2.40 and a beta of 1.34. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.98. Advisory Board has a 12 month low of $30.40 and a 12 month high of $59.50.
A number of research firms recently commented on ABCO. Piper Jaffray Companies set a $51.00 price target on shares of Advisory Board and gave the stock a “hold” rating in a research report on Thursday, August 10th. Oppenheimer reaffirmed an “outperform” rating and set a $56.00 price target (up from $53.00) on shares of Advisory Board in a research report on Thursday, August 10th. Cantor Fitzgerald reissued a “hold” rating on shares of Advisory Board in a report on Friday, November 17th. KeyCorp reissued a “hold” rating on shares of Advisory Board in a report on Friday, September 1st. Finally, Wells Fargo & Company lowered shares of Advisory Board from an “outperform” rating to a “market perform” rating and decreased their target price for the company from $57.00 to $54.00 in a report on Monday, October 2nd. One analyst has rated the stock with a sell rating, twelve have given a hold rating and three have assigned a buy rating to the company’s stock. Advisory Board currently has a consensus rating of “Hold” and a consensus target price of $51.95.
TRADEMARK VIOLATION NOTICE: “Advisory Board (ABCO) Getting Somewhat Favorable Media Coverage, Accern Reports” was reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://www.thelincolnianonline.com/2017/12/07/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-the-advisory-board-abco-stock-price-updated-updated-updated.html.
About Advisory Board
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.
Receive News & Ratings for Advisory Board Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advisory Board and related companies with MarketBeat.com's FREE daily email newsletter.